Vol. 7 No. s8 (2013): The new oral anticoagulants in the Internal Medicine clinical practice

Reviews

• 

  Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

  Luca Masotti, Mauro Campanini

  1-7

  https://doi.org/10.4081/itjm.2013.s8.1

  9479

  PDF: 2669

  • PDF
• 

  Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  8-21

  https://doi.org/10.4081/itjm.2013.s8.8

  1271

  PDF: 835

  • PDF
• 

  Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

  Andrea Rubboli

  22-28

  https://doi.org/10.4081/itjm.2013.s8.22

  952

  PDF: 714

  • PDF
• 

  The treatment of venous thromboembolism with new oral anticoagulants

  Davide Imberti

  29-35

  https://doi.org/10.4081/itjm.2013.s8.29

  1033

  PDF: 811

  • PDF
• 

  How to manage new oral anticoagulants in case of surgery

  Davide Imberti

  36-40

  https://doi.org/10.4081/itjm.2013.s8.36

  876

  PDF: 798

  • PDF
• 

  Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

  Giancarlo Landini, Luca Masotti

  41-47

  https://doi.org/10.4081/itjm.2013.s8.41

  881

  PDF: 773

  • PDF
• 

  The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

  Luca Masotti, Giancarlo Landini, Grazia Panigada

  48-58

  https://doi.org/10.4081/itjm.2013.s8.48

  1322

  PDF: 900

  • PDF
• 

  Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis

  Andrea Fontanella, Pierpaolo Di Micco

  59-64

  https://doi.org/10.4081/itjm.2013.s8.59

  903

  PDF: 881

  • PDF
• 

  New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

  Mauro Silingardi

  65-70

  https://doi.org/10.4081/itjm.2013.s8.65

  1311

  PDF: 922

  • PDF
• 

  The expert in hemostasis and thrombosis in the Italian health system: role and requirements for a specific clinical and laboratory expertise

  Francesco Rodeghiero, Massimo Morfini, Carlo Nozzoli, Cesare Manotti, Francesco Violi, Giuseppe Castaldo, Fabrizio Pane, Bruno Biasioli, Claudio Velati, on behalf of SISET, AICE, FADOI, FCSA, SIBioC, SIE, SIMeL, SIMI, SIMTI

  71-73

  https://doi.org/10.4081/itjm.2013.s8.71

  1225

  PDF: 839

  • PDF
• 

  New oral anticoagulants: key messages for clinicians

  Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

  74-84

  https://doi.org/10.4081/itjm.2013.s8.74

  1236

  PDF: 844

  • PDF